ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

AUTL Autolus Therapeutics PLC

4,19
0,00 (0,00%)
03 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Autolus Therapeutics PLC AUTL NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 4,19 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,19
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
31.5.202414:00GLOBEAutolus Therapeutics presents longer-term follow-up and..
17.5.202422:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17.5.202414:27EDGAR2Form 8-K - Current report
17.5.202413:00GLOBEAutolus Therapeutics Reports First Quarter 2024 Financial..
14.5.202416:00GLOBEAutolus Therapeutics to Present Three Clinical Data Updates..
13.5.202415:33EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
13.5.202413:23EDGAR2Form 8-K - Current report
13.5.202413:00GLOBEAutolus Therapeutics Announces Delay to its First Quarter..
24.4.202416:00GLOBEAbstract for longer-term follow-up and additional data..
23.4.202413:00GLOBEAutolus Therapeutics to Report First Quarter 2024 Financial..
02.4.202413:00GLOBEAutolus Therapeutics announces acceptance of Marketing..
01.4.202413:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
14.3.202412:00GLOBEAutolus Therapeutics Reports Full Year 2023 Financial..
12.3.202412:00GLOBEAutolus Therapeutics receives Medicines and Healthcare..
11.3.202412:00GLOBEAutolus Therapeutics announces publication in Blood Cancer..
29.2.202413:00GLOBEAutolus Therapeutics to Report Full Year 2023 Financial..
23.2.202423:28EDGAR2Form D - Notice of Exempt Offering of Securities
22.2.202413:00GLOBEAutolus Therapeutics announces publication in Nature..
21.2.202423:01EDGAR2Form SC 13D - General statement of acquisition of beneficial..
14.2.202414:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09.2.202423:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08.2.202422:17EDGAR2Form 8-K - Current report
08.2.202413:00GLOBEAutolus Announces Pricing of Underwritten Offering
08.2.202412:06EDGAR2Form 8-K - Current report
08.2.202411:45GLOBEBioNTech and Autolus Announce Strategic CAR-T Cell Therapy..
08.2.202404:00EDGAR2Form S-3ASR - Automatic shelf registration statement of..
31.1.202422:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26.1.202419:02EDGAR2Form 8-K - Current report
23.1.202413:00GLOBEAutolus Therapeutics announces publication in ACS Chemical..
22.1.202413:54DJNAutolus Therapeutics Gets BLA Acceptance for Obecabtagene..
22.1.202413:00GLOBEAutolus Therapeutics announces acceptance of Biologics..
10.1.202421:12EDGAR2Form 8-K - Current report
10.1.202413:00GLOBEAutolus Therapeutics announces the appointment of Robert W...
22.12.202314:24EDGAR2Form 8-K - Current report
22.12.202313:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
11.12.202314:31EDGAR2Form 8-K - Current report
10.12.202302:30GLOBEAutolus Therapeutics Presents Clinical Data Updates at the..
28.11.202320:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
27.11.202313:54DJNAutolus Seeks FDA OK of Obe-Cel in Adult B-Cell Acute..
27.11.202313:07EDGAR2Form 8-K - Current report
27.11.202313:00GLOBEAutolus Therapeutics Submits Biologics License Application..
15.11.202313:00GLOBEAutolus Therapeutics to Host Analyst / Investor event at the..
09.11.202322:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202315:18EDGAR2Form 8-K - Current report
06.11.202313:00GLOBEAutolus Therapeutics announces participation in upcoming..
03.11.202321:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
02.11.202321:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02.11.202314:00GLOBEAutolus Therapeutics to Present Clinical Data Updates at the..
02.11.202312:11GLOBEAutolus Therapeutics Reports Third Quarter 2023 Financial..
17.10.202313:00GLOBEAutolus Therapeutics to host virtual event to discuss the..